Suven Pharmaceuticals Limited SUVENPHAR.NS Stock
Suven Pharmaceuticals Limited Price Chart
Suven Pharmaceuticals Limited SUVENPHAR.NS Financial and Trading Overview
| Suven Pharmaceuticals Limited stock price | 625 INR |
| Previous Close | 477.35 INR |
| Open | 477.35 INR |
| Bid | 483.05 INR x N/A |
| Ask | 483.45 INR x N/A |
| Day's Range | 476.45 - 486.9 INR |
| 52 Week Range | 390.5 - 520 INR |
| Volume | 395.98K INR |
| Avg. Volume | 281.59K INR |
| Market Cap | 123.16B INR |
| Beta (5Y Monthly) | 1.58409 |
| PE Ratio (TTM) | 29.901112 |
| EPS (TTM) | 14.58 INR |
| Forward Dividend & Yield | 3 (0.63%) |
| Ex-Dividend Date | September 9, 2022 |
| 1y Target Est | N/A |
SUVENPHAR.NS Valuation Measures
| Enterprise Value | 117.35B INR |
| Trailing P/E | 29.901112 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.188682 |
| Price/Book (mrq) | 7.097588 |
| Enterprise Value/Revenue | 8.755 |
| Enterprise Value/EBITDA | 20.76 |
Trading Information
Suven Pharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | 1.58409 |
| 52-Week Change | 6.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 520 INR |
| 52 Week Low | 390.5 INR |
| 50-Day Moving Average | 472.89 INR |
| 200-Day Moving Average | 466.81 INR |
SUVENPHAR.NS Share Statistics
| Avg. Volume (3 month) | 281.59K INR |
| Avg. Daily Volume (10-Days) | 226.64K INR |
| Shares Outstanding | 254.56M |
| Float | 95.7M |
| Short Ratio | N/A |
| % Held by Insiders | 64.94% |
| % Held by Institutions | 18.20% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1238 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 30.68% |
| Operating Margin (ttm) | 38.70% |
| Gross Margin | 56.32% |
| EBITDA Margin | 42.17% |
Management Effectiveness
| Return on Assets (ttm) | 17.08% |
| Return on Equity (ttm) | 25.21% |
Income Statement
| Revenue (ttm) | 13.4B INR |
| Revenue Per Share (ttm) | 52.66 INR |
| Quarterly Revenue Growth (yoy) | 1.50% |
| Gross Profit (ttm) | 7.55B INR |
| EBITDA | 5.65B INR |
| Net Income Avi to Common (ttm) | 4.11B INR |
| Diluted EPS (ttm) | 16.18 |
| Quarterly Earnings Growth (yoy) | 35.19% |
Balance Sheet
| Total Cash (mrq) | 4.87B INR |
| Total Cash Per Share (mrq) | 19.13 INR |
| Total Debt (mrq) | 703.41M INR |
| Total Debt/Equity (mrq) | 4.05 INR |
| Current Ratio (mrq) | 6.368 |
| Book Value Per Share (mrq) | 68.164 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.51B INR |
| Levered Free Cash Flow (ttm) | 1.11B INR |
Profile of Suven Pharmaceuticals Limited
| Country | India |
| State | N/A |
| City | Hyderabad |
| Address | # 8-2-334, SDE Serene Chambers |
| ZIP | 500034 |
| Phone | 91 40 2354 9414 |
| Website | https://www.suvenpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.
Q&A For Suven Pharmaceuticals Limited Stock
What is a current SUVENPHAR.NS stock price?
Suven Pharmaceuticals Limited SUVENPHAR.NS stock price today per share is 625 INR.
How to purchase Suven Pharmaceuticals Limited stock?
You can buy SUVENPHAR.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Suven Pharmaceuticals Limited?
The stock symbol or ticker of Suven Pharmaceuticals Limited is SUVENPHAR.NS.
Which industry does the Suven Pharmaceuticals Limited company belong to?
The Suven Pharmaceuticals Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Suven Pharmaceuticals Limited have in circulation?
The max supply of Suven Pharmaceuticals Limited shares is 254.56M.
What is Suven Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
Suven Pharmaceuticals Limited PE Ratio is 42.86694000 now.
What was Suven Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
Suven Pharmaceuticals Limited EPS is 14.58 INR over the trailing 12 months.
Which sector does the Suven Pharmaceuticals Limited company belong to?
The Suven Pharmaceuticals Limited sector is Healthcare.